Hypermarcas (OTCMKTS:HYPMY - Get Free Report) was upgraded by research analysts at Scotiabank to a "strong-buy" rating in a research report issued on Thursday,Zacks.com reports.
Hypermarcas Price Performance
Shares of Hypermarcas stock traded up $0.19 on Thursday, hitting $4.83. 197 shares of the company were exchanged, compared to its average volume of 264,768. The stock has a market capitalization of $3.06 billion, a price-to-earnings ratio of 20.10 and a beta of 0.81. The company has a 50-day moving average price of $4.66 and a 200 day moving average price of $3.82. Hypermarcas has a 1-year low of $2.64 and a 1-year high of $5.92. The company has a quick ratio of 0.80, a current ratio of 1.26 and a debt-to-equity ratio of 0.63.
Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The company reported ($0.04) earnings per share for the quarter. Hypermarcas had a return on equity of 6.95% and a net margin of 12.51%. The company had revenue of $184.34 million for the quarter.
Hypermarcas Company Profile
(
Get Free Report)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Featured Stories
Before you consider Hypermarcas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hypermarcas wasn't on the list.
While Hypermarcas currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
